Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-11-25

Clinical Trial Update: Assessment of Drug-drug Interactions Between Masculinizing Hormone Therapy and Antiretroviral Agents Concomitantly for Pre-exposure Prophylaxis Among Transgender Men [NA]

View source ↗

Summary

This clinical trial update investigates potential drug-drug interactions between masculinizing hormone therapy and antiretroviral agents used for HIV pre-exposu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Antiretroviral agents for pre-exposure prophylaxis (PrEP)
  • Masculinizing hormone therapy (testosterone-based hormone therapy)

Snippet

Sponsor: Thai Red Cross AIDS Research Centre | Conditions: Drug Interaction | NA | Status: ACTIVE_NOT_RECRUITING